🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/05/2013 | 16,77 | 16,90 | 16,54 | 16,65 | -0,74% | 2,16% | 96.661 |
| 15/05/2013 | 16,69 | 16,89 | 16,57 | 16,77 | +0,56% | 1,94% | 243.175 |
| 14/05/2013 | 16,72 | 17,04 | 16,58 | 16,68 | +0,04% | 2,72% | 258.885 |
| 13/05/2013 | 16,73 | 16,97 | 16,48 | 16,68 | +0,11% | 2,95% | 398.185 |
| 10/05/2013 | 16,57 | 17,11 | 16,40 | 16,66 | +0,38% | 4,25% | 304.089 |
| 09/05/2013 | 16,97 | 17,75 | 16,51 | 16,59 | -0,97% | 7,35% | 332.462 |
| 08/05/2013 | 16,86 | 16,95 | 16,57 | 16,76 | +2,71% | 2,26% | 460.702 |
| 07/05/2013 | 16,20 | 16,53 | 16,04 | 16,31 | +0,58% | 3,00% | 440.504 |
| 06/05/2013 | 16,48 | 16,48 | 15,97 | 16,22 | -0,80% | 3,07% | 305.051 |
| 03/05/2013 | 16,62 | 17,07 | 16,31 | 16,35 | +0,00% | 4,58% | 203.902 |
| 02/05/2013 | 16,32 | 16,66 | 16,23 | 16,35 | +1,00% | 2,68% | 268.503 |
| 01/05/2013 | 16,94 | 16,94 | 16,13 | 16,19 | -5,01% | 4,82% | 236.282 |
| 30/04/2013 | 17,26 | 17,77 | 16,88 | 17,04 | -0,94% | 5,17% | 115.095 |
| 29/04/2013 | 17,04 | 17,35 | 16,36 | 17,21 | +1,10% | 5,78% | 185.307 |
| 26/04/2013 | 17,47 | 17,54 | 16,87 | 17,02 | -2,71% | 3,79% | 215.123 |
| 25/04/2013 | 17,22 | 17,70 | 17,18 | 17,49 | +2,34% | 3,04% | 81.432 |
| 24/04/2013 | 17,37 | 17,37 | 16,91 | 17,09 | -1,93% | 2,66% | 346.889 |
| 23/04/2013 | 17,86 | 18,67 | 17,21 | 17,43 | -0,25% | 8,14% | 514.563 |
| 22/04/2013 | 16,89 | 17,62 | 16,84 | 17,47 | +4,05% | 4,65% | 276.838 |
| 19/04/2013 | 15,44 | 17,04 | 15,44 | 16,79 | +10,33% | 10,34% | 287.418 |
| 18/04/2013 | 15,33 | 15,33 | 14,92 | 15,22 | -0,93% | 2,69% | 152.926 |
| 17/04/2013 | 15,53 | 15,60 | 14,89 | 15,36 | -1,91% | 4,54% | 156.613 |
| 16/04/2013 | 15,08 | 15,74 | 15,00 | 15,66 | +4,54% | 4,92% | 209.031 |
| 15/04/2013 | 16,12 | 16,18 | 14,66 | 14,98 | -7,40% | 9,40% | 424.955 |
| 12/04/2013 | 15,78 | 16,63 | 15,78 | 16,18 | +1,81% | 5,42% | 205.344 |
| 11/04/2013 | 15,97 | 16,09 | 15,76 | 15,90 | -0,89% | 2,11% | 126.316 |
| 10/04/2013 | 15,85 | 16,17 | 15,71 | 16,04 | +1,38% | 2,91% | 159.979 |
| 09/04/2013 | 16,05 | 16,18 | 15,78 | 15,82 | -0,94% | 2,53% | 78.547 |
| 08/04/2013 | 16,19 | 16,28 | 15,60 | 15,97 | -0,77% | 4,16% | 125.515 |
| 05/04/2013 | 15,85 | 16,20 | 15,85 | 16,09 | -0,50% | 2,20% | 105.638 |